Filter your results
- 2
- 2
- 2
- 1
- 1
- 2
- 1
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis BHepatology Communications, 2019, 4 (1), pp.8-20. ⟨10.1002/hep4.1436⟩
Journal articles
hal-03932571v1
|
||
|
Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort studyAlimentary Pharmacology & Therapeutics (Suppl), 2020, 52 (3), pp.500-512. ⟨10.1111/apt.15901⟩
Journal articles
hal-03933002v1
|